EAACI Portal

Eaaci: European Academy of Allergy and Clinical Immunology

UPCOMING EVENTS

    PAAM Digital 2021, Pediatric Allergy and Asthma Meeting
    12 - 13 November 2021
    Digital Event
    Winter School on Basic Immunology Research in Allergy and Clinical Immunology 2022
    27 - 30 January 2022
    Format to be announced
    Save the date
ALL, PAI & CTA
Journals
EAACI Guidelines
Guidelines
Global Atlases
Books
Overview of active Task Forces
Task Forces
All webcasts from EAACI Meetings
Webcasts
Visit the EAACI Media Library
Media Library
All EAACI news
Newsletter
Important EAACI publications
Position Papers
Read the first edition of our EAACI Review!
8923w3Share
We invite you to read the very first edition of the "EAACI Review" - a collection of salient news, exciting testimonials from our EAACI Community, and important information about upcoming and past events. In this issue find the Public Outreach Task Force Cartoon video on COVID-10; work from the EAACI Task Force on Lipid Transfer Protein Allergy across Europe; the promotion of the Allergy College at the upcoming EAACI Hybrid Congress 2021, and much more. Do you have an important update to share ...
EAACI Global Atlas of Asthma 2021 Update
49093m12Share
Asthma is a major public health problem affecting more than 350 million patients around the world. Its prevalence and impact are particularly on the rise in urbanized regions and expanding worldwide, associated with environmental and lifestyle changes. It is representing the most prevalent chronic childhood disease and one of the highest causes of health care costs.We are launching the update (2nd Edition) of the Global Atlas of Asthma aiming to provide a platform for strategic planning for asth...
Access all our previous articles
& newsletters in PDF format.
Launch of the EAACI Guidelines – Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years old
2316h0Share
We are proud to announce the launch of the new EAACI Guidelines on Omalizumab for the treatment of Chronic Spontaneous Urticaria, a major scientific output of 2021 for the Academy....
Call for Public Review: Establishment and validation of combined symptom-medication scores for allergic rhinitis
2412w1Share
For the investigation, evaluation and authorization of medicinal products in allergic rhinitis, validated scoring methods of analyzing effect sizes are requested (EMA 20081). To da...
Submit now your abstract to PAAM Digital 2021
3614w1Share
We invite you to submit your abstract to the Pediatric Allergy and Asthma Meeting (PAAM Digital 2021), taking place on 12-13 November 2021. The deadline to submit your abstract(s) ...
Visit the EAACI Hybrid Congress 2021 Digital Platform!
7181m2Share
We are counting down the days to e-welcome you to the EAACI Hybrid Congress 2021 meeting! Before we kick-off on Saturday 10 July, we invite you to explore the platform, which is no...
EAACI mourns the loss of Marek Kowalski
12561m7Share
It is with great regret that we inform you of the passing of our esteemed colleague Marek L. Kowalski on June 22 2021. Prof. Kowalski was Professor and Chair of Clinical Immunology...
EAACI Working Group on Primary Care’s survey of general practitioners: update
9842m2Share
In 2019, the EAACI Working Group on Primary Care invited EAACI members to work with us to identify the needs of European general medical practitioners (GPs) with regards to allergi...
EAACI Task Force on Conscious and rational use of antibiotics in allergic diseases
9782m2Share
Rational use of antibiotics has become an essential topic in clinical care, mainly because of emerging antimicrobial resistance which is a threat to global health. Patients with al...
NAS Junior Committee translation activity: EAACI needs YOU!
15082m9Share
The National Allergy Societies Junior Committee (NAS-JM) is a shared platform promoted by the EAACI National Allergy Societies Committee and Junior Member Assembly to increase the ...
Next
EAACI Advocacy – Celebrating the World Day of Asthma
23553m3Share
With more than 350 million patients affected around the world, asthma prevalence and impact are on the rise, associated with environmental and lifestyle changes. Asthma is the mo...
Transitional deals available for EAACI Journals
16163m1Share
Aligned with the current effort of the scientific community towards higher  democratization of knowledge through the Open Access publishing model, EAACI and its partner publis...
EAACI Advocacy – Celebrating the International Day of Immunology with Top Research News
16873m5Share
On the International Day of Immunology, the European Academy of Allergy and Clinical Immunology would like to highlight three important topics revolving around current immunology r...
EAACI Advocacy - World Day for Safety and Health at Work
17953m5Share
EAACI Advocacy - World Day for Safety and Health at Work: every effort should be made to keep the workplace safe and healthy On the occasion of World Day for Safety and Health at ...
Result from Extraordinary General Assembly March 2021
16884m2Share
We would like to provide you the outcome of the EAACI Extraordinary General Assembly which took place on Friday 26 March 2021, 09:00 – 10:00 CET. After presentation of the propo...
Save the Date - 13th EAACI/UEMS Knowledge Exam
20504m6Share
13th EAACI/UEMS Knowledge Exam SAVE THE DATE for the 13th EAACI/UEMS Knowledge Exam which will take place fully digital on Monday, 18th October 2021 at 13:00 CET. Train your skills...
EAACI-EFA Statement integrated within Europe’s Beating Cancer Plan
18164m2Share
On 3 February 2021, the European Commission presented Europe's Beating Cancer plan. The plan is a key European Union public health initiative and a cornerstone of the European heal...
World Meteorological Day, 23 March 2021 - Climate change: a profound impact on asthma and allergy sufferers
34444m5Share
On the occasion of World Meteorological Day 23 March 2021, the European Academy of Allergy Asthma and Clinical Immunology (EAACI), the European Federation of Allergy and Airways Di...
Previous
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel